Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Department of Ob/Gyn, Duke University Medical Center, Durham, NC, USA.
Int Urogynecol J. 2023 Nov;34(11):2689-2699. doi: 10.1007/s00192-023-05660-9. Epub 2023 Oct 11.
This manuscript of Chapter 4 of the International Urogynecological Consultation (IUC) on Pelvic Organ Prolapse (POP) reviews the literature and makes recommendations on the definition of success in the surgical treatment of pelvic organ prolapse.
An international group containing seven urogynecologists performed an exhaustive search of the literature using two PubMed searches and using PICO methodology. The first search was from 01/01/2012-06/12/2022. A second search from inception to 7/24/2022 was done to access older references. Publications were eliminated if not relevant to the clinical definition of surgical success for the treatment of POP. All abstracts were reviewed for inclusion and any disagreements were adjudicated by majority consensus of the writing group. The resulting list of articles were used to inform a comprehensive review and creation of the definition of success in the surgical treatment of POP.
The original search yielded 12,161 references of which 45 were used by the writing group. Ultimately, 68 references are included in the manuscript. For research purposes, surgical success should be primarily defined by the absence of bothersome patient bulge symptoms or retreatment for POP and a time frame of at least 12 months follow-up should be used. Secondary outcomes, including anatomic measures of POP and related pelvic floor symptoms, should not contribute to a definition of success or failure. For clinical practice, surgical success should primarily be defined as the absence of bothersome patient bulge symptoms. Surgeons may consider using PASS (patient acceptable symptom state) or patient goal attainment assessments, and patients should be followed for a minimum of at least one encounter at 6-12 weeks post-operatively. For surgeries involving mesh longer-term follow-up is recommended.
本文是国际女性盆底咨询委员会(IUC)第 4 章关于盆腔器官脱垂(POP)的手稿,回顾了文献并就盆腔器官脱垂手术治疗成功的定义提出了建议。
由 7 名尿妇科医生组成的国际小组,使用两种 PubMed 搜索和 PICO 方法,对文献进行了详尽的搜索。第一次搜索的时间范围是 2012 年 1 月 1 日至 2022 年 6 月 12 日。为了获取更早期的参考文献,还进行了第二次从创建到 2022 年 7 月 24 日的搜索。如果与 POP 治疗的手术成功的临床定义不相关,则排除出版物。所有摘要均进行了审查以确定是否符合纳入标准,任何分歧均由写作小组的多数意见裁决。由此产生的文章列表用于提供信息,以全面审查并创建盆腔器官脱垂手术治疗成功的定义。
原始搜索产生了 12161 条参考文献,其中 45 条被写作小组使用。最终,有 68 篇参考文献包含在本文中。出于研究目的,手术成功主要应定义为无烦扰的患者膨出症状或 POP 的再次治疗,且应使用至少 12 个月的随访时间框架。次要结果,包括 POP 的解剖学测量和相关的盆底症状,不应作为成功或失败的定义因素。对于临床实践,手术成功主要应定义为无烦扰的患者膨出症状。外科医生可以考虑使用 PASS(患者可接受的症状状态)或患者目标实现评估,并且患者应至少在术后 6-12 周进行一次随访。对于涉及网片的手术,建议进行长期随访。